Robeco Institutional Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201M | Buy |
404,396
+2,752
| +0.7% | +$1.22M | 0.25% | 100 |
|
|
2026
Q1 | $179M | Buy |
401,644
+7,444
| +2% | +$3.47M | 0.26% | 109 |
|
|
2025
Q4 | $179M | Buy |
394,200
+14,829
| +4% | +$6.39M | 0.25% | 99 |
|
|
2025
Q3 | $149M | Buy |
379,371
+49,980
| +15% | +$20.9M | 0.22% | 112 |
|
|
2025
Q2 | $147M | Buy |
329,391
+183,391
| +126% | +$84.5M | 0.24% | 105 |
|
|
2025
Q1 | $70.8M | Sell |
146,000
-140,756
| -49% | -$65.6M | 0.14% | 154 |
|
|
2024
Q4 | $115M | Sell |
286,756
-9,812
| -3% | -$4.55M | 0.22% | 100 |
|
|
2024
Q3 | $138M | Sell |
296,568
-73,643
| -20% | -$35.4M | 0.27% | 81 |
|
|
2024
Q2 | $174M | Sell |
370,211
-93,658
| -20% | -$40.7M | 0.37% | 58 |
|
|
2024
Q1 | $194M | Buy |
463,869
+6,045
| +1% | +$2.56M | 0.42% | 52 |
|
|
2023
Q4 | $186M | Buy |
457,824
+24,887
| +6% | +$9.19M | 0.45% | 56 |
|
|
2023
Q3 | $151M | Buy |
432,937
+26,523
| +7% | +$9.28M | 0.4% | 61 |
|
|
2023
Q2 | $143M | Sell |
406,414
-40,403
| -9% | -$13.6M | 0.38% | 67 |
|
|
2023
Q1 | $141M | Sell |
446,817
-25,140
| -5% | -$7.54M | 0.38% | 67 |
|
|
2022
Q4 | $136M | Buy |
471,957
+132,927
| +39% | +$40.5M | 0.39% | 70 |
|
|
2022
Q3 | $98.2M | Buy |
339,030
+85,003
| +33% | +$24.5M | 0.32% | 82 |
|
|
2022
Q2 | $71.6M | Buy |
254,027
+17,195
| +7% | +$4.6M | 0.22% | 108 |
|
|
2022
Q1 | $61.8M | Buy |
236,832
+38,514
| +19% | +$9.14M | 0.15% | 167 |
|
|
2021
Q4 | $43.6M | Sell |
198,318
-4,637
| -2% | -$902K | 0.09% | 237 |
|
|
2021
Q3 | $36.8M | Sell |
202,955
-132
| -0.1% | -$25.8K | 0.08% | 260 |
|
|
2021
Q2 | $41M | Buy |
203,087
+26,595
| +15% | +$5.56M | 0.09% | 239 |
|
|
2021
Q1 | $37.9M | Sell |
176,492
-112,005
| -39% | -$24.6M | 0.09% | 239 |
|
|
2020
Q4 | $68.2M | Sell |
288,497
-67,392
| -19% | -$15.5M | 0.18% | 144 |
|
|
2020
Q3 | $96.8M | Buy |
355,889
+47,537
| +15% | +$13.1M | 0.3% | 90 |
|
|
2020
Q2 | $89.5M | Buy |
308,352
+228,379
| +286% | +$61.9M | 0.3% | 85 |
|
|
2020
Q1 | $19M | Buy |
79,973
+47,325
| +145% | +$10.9M | 0.08% | 291 |
|
|
2019
Q4 | $7.15M | Buy |
32,648
+3,938
| +14% | +$797K | 0.02% | 544 |
|
|
2019
Q3 | $4.86M | Sell |
28,710
-8,982
| -24% | -$1.59M | 0.02% | 594 |
|
|
2019
Q2 | $6.91M | Sell |
37,692
-3,294
| -8% | -$576K | 0.02% | 542 |
|
|
2019
Q1 | $7.54M | Buy |
40,986
+15,783
| +63% | +$2.92M | 0.03% | 519 |
|
|
2018
Q4 | $4.18M | Sell |
25,203
-12,012
| -32% | -$2.08M | 0.02% | 569 |
|
|
2018
Q3 | $7.17M | Buy |
37,215
+2,636
| +8% | +$469K | 0.03% | 502 |
|
|
2018
Q2 | $5.88M | Sell |
34,579
-2,049
| -6% | -$318K | 0.03% | 498 |
|
|
2018
Q1 | $5.97M | Buy |
36,628
+9,940
| +37% | +$1.62M | 0.03% | 494 |
|
|
2017
Q4 | $4M | Buy |
26,688
+11,016
| +70% | +$1.63M | 0.02% | 529 |
|
|
2017
Q3 | $2.38M | Buy |
15,672
+39
| +0.2% | +$5.87K | 0.01% | 557 |
|
|
2017
Q2 | $2.01M | Buy |
15,633
+14,672
| +1,527% | +$1.77M | 0.01% | 586 |
|
|
2017
Q1 | $105K | Hold |
961
| – | – | ﹤0.01% | 826 |
|
|
2016
Q4 | $71K | Hold |
961
| – | – | ﹤0.01% | 768 |
|
|
2016
Q3 | $84K | Sell |
961
-9,767
| -91% | -$923K | ﹤0.01% | 773 |
|
|
2016
Q2 | $923K | Hold |
10,728
| – | – | 0.01% | 607 |
|
|
2016
Q1 | $853K | Hold |
10,728
| – | – | 0.01% | 617 |
|
|
2015
Q4 | $1.35M | Buy |
10,728
+2,605
| +32% | +$314K | 0.01% | 551 |
|
|
2015
Q3 | $846K | Hold |
8,123
| – | – | 0.01% | 578 |
|
|
2015
Q2 | $1M | Buy |
8,123
+7,660
| +1,654% | +$965K | 0.01% | 587 |
|
|
2015
Q1 | $55K | Sell |
463
-6,223
| -93% | -$746K | ﹤0.01% | 750 |
|
|
2014
Q4 | $794K | Buy |
6,686
+2,592
| +63% | +$292K | 0.01% | 584 |
|
|
2014
Q3 | $460K | Buy |
4,094
+724
| +21% | +$68.9K | ﹤0.01% | 618 |
|
|
2014
Q2 | $319K | Buy |
3,370
+1,521
| +82% | +$107K | ﹤0.01% | 639 |
|
|
2014
Q1 | $131K | Buy |
1,849
+542
| +41% | +$42.9K | ﹤0.01% | 626 |
|
|
2013
Q4 | $97K | Hold |
1,307
| – | – | ﹤0.01% | 557 |
|
|
2013
Q3 | $99K | Hold |
1,307
| – | – | ﹤0.01% | 563 |
|
|
2013
Q2 | $104K | Buy |
+1,307
| New | +$96.3K | ﹤0.01% | 552 |
|
Other funds holding VRTX
Robeco Institutional Asset Management's VRTX Position: Q2 2026 in Review
Robeco Institutional Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.69% in Q2 2026, buying an estimated $1.22M and bringing the position to 404,396 shares worth $201M. The position accounts for 0.25% of the portfolio, ranked #100.
Robeco Institutional Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Robeco Institutional Asset Management held 404,396 shares of Vertex Pharmaceuticals worth $201M as of Q2 2026.
- Robeco Institutional Asset Management bought 2,752 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
- Vertex Pharmaceuticals made up 0.25% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #100 holding.
- Robeco Institutional Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.